Loading...

North American Automation And Life Sciences Will Create Future Opportunities

Published
30 Dec 24
Updated
04 Sep 25
AnalystConsensusTarget's Fair Value
CA$47.80
21.4% undervalued intrinsic discount
04 Sep
CA$37.55
Loading
1Y
-7.9%
7D
4.8%

Author's Valuation

CA$47.821.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Sep 25

With no change in both the Future P/E (9.94x) and Discount Rate (7.92%), the consensus analyst price target for ATS also remained steady at CA$47.80. What's in the News ATS issued Q2 FY26 revenue guidance of $700 million to $740 million.

Shared on01 May 25
Fair value Increased 2.19%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.021%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 7.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 1.65%

AnalystConsensusTarget has increased revenue growth from 2.9% to 6.8%, increased profit margin from 6.1% to 7.7% and decreased future PE multiple from 37.2x to 24.1x.